Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Organ Transplant Immunosuppressant Drugs
Revenue, means the sales value of Organ Transplant Immunosuppressant Drugs
This report studies sales (consumption) of Organ Transplant Immunosuppressant Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
AstellasPharma
Genzyme Corporation
Watson Pharmaceuticals
Novartis AG
Mylan Laboratories
GlaxoSmithKline plc
Hoffman La Roche
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Organ Transplant Immunosuppressant Drugs in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Zenapax
Prograf
Cellcept
Myfortic
Neoral
Other
Split by application, this report focuses on sales, market share and growth rate of Organ Transplant Immunosuppressant Drugs in each application, can be divided into
Heart Transplant
Lung Transplant
Kidney Transplant
Liver Transplant
Other
Europe Organ Transplant Immunosuppressant Drugs Market Report 2017
1 Organ Transplant Immunosuppressant Drugs Overview
1.1 Product Overview and Scope of Organ Transplant Immunosuppressant Drugs
1.2 Classification of Organ Transplant Immunosuppressant Drugs
1.2.1 Zenapax
1.2.2 Prograf
1.2.3 Cellcept
1.2.4 Myfortic
1.2.5 Neoral
1.2.6 Other
1.3 Application of Organ Transplant Immunosuppressant Drugs
1.3.1 Heart Transplant
1.3.2 Lung Transplant
1.3.3 Kidney Transplant
1.3.4 Liver Transplant
1.3.5 Other
1.4 Organ Transplant Immunosuppressant Drugs Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Organ Transplant Immunosuppressant Drugs (2012-2022)
1.5.1 Europe Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2022)
1.5.2 Europe Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)
2 Europe Organ Transplant Immunosuppressant Drugs by Manufacturers, Type and Application
2.1 Europe Organ Transplant Immunosuppressant Drugs Market Competition by Manufacturers
2.1.1 Europe Organ Transplant Immunosuppressant Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Organ Transplant Immunosuppressant Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Organ Transplant Immunosuppressant Drugs (Volume and Value) by Type
2.2.1 Europe Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Europe Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Type (2012-2017)
2.3 Europe Organ Transplant Immunosuppressant Drugs (Volume and Value) by Countries
2.3.1 Europe Organ Transplant Immunosuppressant Drugs Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Countries (2012-2017)
2.4 Europe Organ Transplant Immunosuppressant Drugs (Volume) by Application
3 Germany Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)
3.1 Germany Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)
3.1.1 Germany Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
3.1.2 Germany Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
3.1.3 Germany Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
3.2 Germany Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers
3.3 Germany Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type
3.4 Germany Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application
4 France Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)
4.1 France Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)
4.1.1 France Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
4.1.2 France Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
4.1.4 France Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
4.2 France Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers
4.3 France Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type
4.4 France Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application
5 UK Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)
5.1 UK Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)
5.1.1 UK Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
5.1.2 UK Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
5.1.5 UK Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
5.2 UK Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers
5.3 UK Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type
5.4 UK Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application
6 Russia Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)
6.1 Russia Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)
6.1.1 Russia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
6.1.2 Russia Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
6.1.6 Russia Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
6.2 Russia Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers
6.3 Russia Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type
6.4 Russia Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application
7 Italy Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)
7.1 Italy Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)
7.1.1 Italy Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
7.1.2 Italy Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
7.1.7 Italy Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
7.2 Italy Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers
7.3 Italy Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type
7.4 Italy Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application
8 Spain Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)
8.1 Spain Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)
8.1.1 Spain Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
8.1.2 Spain Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
8.1.8 Spain Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
8.2 Spain Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers
8.3 Spain Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type
8.4 Spain Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application
9 Benelux Organ Transplant Immunosuppressant Drugs (Volume, Value and Sales Price)
9.1 Benelux Organ Transplant Immunosuppressant Drugs Sales and Value (2012-2017)
9.1.1 Benelux Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
9.1.2 Benelux Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
9.2 Benelux Organ Transplant Immunosuppressant Drugs Sales and Market Share by Manufacturers
9.3 Benelux Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type
9.4 Benelux Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application
10 Europe Organ Transplant Immunosuppressant Drugs Manufacturers Analysis
10.1 AstellasPharma
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification
10.1.2.1 Zenapax
10.1.2.2 Prograf
10.1.3 AstellasPharma Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Genzyme Corporation
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification
10.2.2.1 Zenapax
10.2.2.2 Prograf
10.2.3 Genzyme Corporation Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Watson Pharmaceuticals
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification
10.3.2.1 Zenapax
10.3.2.2 Prograf
10.3.3 Watson Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Novartis AG
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification
10.4.2.1 Zenapax
10.4.2.2 Prograf
10.4.3 Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Mylan Laboratories
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification
10.5.2.1 Zenapax
10.5.2.2 Prograf
10.5.3 Mylan Laboratories Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 GlaxoSmithKline plc
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification
10.6.2.1 Zenapax
10.6.2.2 Prograf
10.6.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Hoffman La Roche
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Organ Transplant Immunosuppressant Drugs Product Type, Application and Specification
10.7.2.1 Zenapax
10.7.2.2 Prograf
10.7.3 Hoffman La Roche Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
11 Organ Transplant Immunosuppressant Drugs Manufacturing Cost Analysis
11.1 Organ Transplant Immunosuppressant Drugs Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Organ Transplant Immunosuppressant Drugs
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Organ Transplant Immunosuppressant Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Organ Transplant Immunosuppressant Drugs Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Organ Transplant Immunosuppressant Drugs Market Forecast (2017-2022)
14.1 Germany Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)
14.2 France Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)
14.3 UK Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)
14.4 Russia Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)
14.5 Italy Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)
14.6 Spain Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)
14.7 Benelux Organ Transplant Immunosuppressant Drugs Sales Forecast (2017-2022)
14.8 Europe Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2017-2022)
14.9 Europe Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Organ Transplant Immunosuppressant Drugs
Table Classification of Organ Transplant Immunosuppressant Drugs
Figure Europe Sales Market Share of Organ Transplant Immunosuppressant Drugs by Type in 2015
Figure Zenapax Picture
Figure Prograf Picture
Figure Cellcept Picture
Figure Myfortic Picture
Figure Neoral Picture
Figure Other Picture
Table Application of Organ Transplant Immunosuppressant Drugs
Figure Europe Sales Market Share of Organ Transplant Immunosuppressant Drugs by Application in 2015
Figure Heart Transplant Examples
Figure Lung Transplant Examples
Figure Kidney Transplant Examples
Figure Liver Transplant Examples
Figure Other Examples
Figure Germany Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)
Figure France Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)
Figure UK Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)
Figure Russia Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)
Figure Italy Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)
Figure Spain Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)
Figure Benelux Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2022)
Figure Europe Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2022)
Table Europe Organ Transplant Immunosuppressant Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturers
Figure 2016 Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturers
Table Europe Organ Transplant Immunosuppressant Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers
Table 2016 Europe Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers
Table Europe Organ Transplant Immunosuppressant Drugs Sales and Market Share by Type (2012-2017)
Table Europe Organ Transplant Immunosuppressant Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Organ Transplant Immunosuppressant Drugs by Type (2012-2017)
Figure Europe Organ Transplant Immunosuppressant Drugs Sales Growth Rate by Type (2012-2017)
Table Europe Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Type (2012-2017)
Table Europe Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Organ Transplant Immunosuppressant Drugs by Type (2012-2017)
Figure Europe Organ Transplant Immunosuppressant Drugs Revenue Growth Rate by Type (2012-2017)
Table Europe Organ Transplant Immunosuppressant Drugs Sales and Market Share by Countries (2012-2017)
Table Europe Organ Transplant Immunosuppressant Drugs Sales Share by Countries (2012-2017)
Figure Sales Market Share of Organ Transplant Immunosuppressant Drugs by Countries (2012-2017)
Table Europe Organ Transplant Immunosuppressant Drugs Revenue and Market Share by Countries (2012-2017)
Table Europe Organ Transplant Immunosuppressant Drugs Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Organ Transplant Immunosuppressant Drugs by Countries (2012-2017)
Table Europe Organ Transplant Immunosuppressant Drugs Sales and Market Share by Application (2012-2017)
Table Europe Organ Transplant Immunosuppressant Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Organ Transplant Immunosuppressant Drugs by Application (2012-2017)
Figure Germany Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
Figure Germany Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
Figure Germany Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
Table Germany Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)
Table Germany Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)
Table Germany Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)
Table Germany Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)
Figure France Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
Figure France Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
Figure France Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
Table France Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)
Table France Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)
Table France Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)
Table France Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)
Table France Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)
Table France Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)
Figure UK Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
Figure UK Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
Figure UK Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
Table UK Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)
Table UK Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)
Table UK Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)
Table UK Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)
Table UK Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)
Figure Russia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
Figure Russia Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
Figure Russia Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
Table Russia Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)
Table Russia Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)
Table Russia Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)
Table Russia Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)
Figure Italy Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
Figure Italy Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
Figure Italy Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
Table Italy Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)
Table Italy Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)
Table Italy Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)
Table Italy Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)
Figure Spain Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
Figure Spain Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
Figure Spain Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
Table Spain Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)
Table Spain Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)
Table Spain Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)
Table Spain Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)
Figure Benelux Organ Transplant Immunosuppressant Drugs Sales and Growth Rate (2012-2017)
Figure Benelux Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate (2012-2017)
Figure Benelux Organ Transplant Immunosuppressant Drugs Sales Price Trend (2012-2017)
Table Benelux Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Organ Transplant Immunosuppressant Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Organ Transplant Immunosuppressant Drugs Sales by Type (2015 and 2016)
Table Benelux Organ Transplant Immunosuppressant Drugs Market Share by Type (2015 and 2016)
Table Benelux Organ Transplant Immunosuppressant Drugs Sales by Application (2015 and 2016)
Table Benelux Organ Transplant Immunosuppressant Drugs Market Share by Application (2015 and 2016)
Table Organ Transplant Immunosuppressant Drugs Basic Information List
Table AstellasPharma Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstellasPharma Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Genzyme Corporation Basic Information List
Table Genzyme Corporation Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Genzyme Corporation Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Watson Pharmaceuticals Basic Information List
Table Watson Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Watson Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Mylan Laboratories Basic Information List
Table Mylan Laboratories Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mylan Laboratories Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Hoffman La Roche Basic Information List
Table Hoffman La Roche Organ Transplant Immunosuppressant Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hoffman La Roche Organ Transplant Immunosuppressant Drugs Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Organ Transplant Immunosuppressant Drugs
Figure Manufacturing Process Analysis of Organ Transplant Immunosuppressant Drugs
Figure Organ Transplant Immunosuppressant Drugs Industrial Chain Analysis
Table Raw Materials Sources of Organ Transplant Immunosuppressant Drugs Major Manufacturers in 2015
Table Major Buyers of Organ Transplant Immunosuppressant Drugs
Table Distributors/Traders List
Figure Germany Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Germany Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure France Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)
Figure France Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure UK Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)
Figure UK Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Russia Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Italy Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Spain Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Organ Transplant Immunosuppressant Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Organ Transplant Immunosuppressant Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Europe Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2017-2022)
Table Europe Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...